Lumexa Imaging Holdings, Inc. (LMRI) Stock Analysis
Lumexa is a leveraged outpatient imaging compounder trading at a steep discount after an accounting-driven selloff, with de novos, health-system joint ventures and debt reduction offering substantial rerating potential.
Overview
Lumexa Imaging is a scaled U.S. outpatient diagnostic imaging consolidator operating more than 190 centers across 13 states, focused on lower-cost, high-quality alternatives to hospital imaging. Its core Outpatient Imaging Centers segment generates most revenue, supported by Professional Services and Connexia teleradiology. The company benefits from strong commercial payor steering, 4 million annual scans, 102,000 referring physicians, high patient and physician satisfaction, and exposure to a growing $33 billion outpatient imaging market.